Immunosuppressive nanoparticles containing recombinant PD-L1 and methotrexate alleviate multi-organ inflammation DOI

Eun‐Koung An,

Wei Zhang,

Hae‐Bin Park

et al.

Biomaterials, Journal Year: 2023, Volume and Issue: 301, P. 122233 - 122233

Published: June 28, 2023

Language: Английский

PD-L1 deglycosylation promotes its nuclear translocation and accelerates DNA double-strand-break repair in cancer DOI Creative Commons
Zhen Shu, Bhakti Dwivedi, Jeffrey M. Switchenko

et al.

Nature Communications, Journal Year: 2024, Volume and Issue: 15(1)

Published: Aug. 9, 2024

Resistance to radiotherapy is a major barrier during cancer treatment. Here using genome-scale CRISPR/Cas9 screening, we identify CD274 gene, which encodes PD-L1, confer lung cell resistance ionizing radiation (IR). Depletion of endogenous PD-L1 delays the repair IR-induced DNA double-strand breaks (DSBs) and loss downregulates non-homologous end joining (NHEJ) while overexpression upregulates NHEJ. IR induces translocation from membrane into nucleus dependent on deglycosylation at N219 CMTM6 leads recruitment DSBs foci. interacts with Ku in enhances binding DSB DNA. The interaction between IgC domain core required for accelerate NHEJ-mediated produce radioresistance. Thus, addition its immune inhibitory activity, acts as mechanistic driver cancer. authors find that radiation-induced double-strand-breaks facilitate nucleus, leading promotion

Language: Английский

Citations

6

Research progress on mitochondria regulating tumor immunity DOI
Jing Li, Pinglong Xu, Shasha Chen

et al.

Journal of Zhejiang University (Medical Sciences), Journal Year: 2024, Volume and Issue: 53(1), P. 1 - 14

Published: Jan. 5, 2024

Tumor cells adapt their metabolism to meet the demands for energy and biosynthesis. Mitochondria, pivotal organelles in metabolic reprogramming of tumor cells, contribute tumorigenesis cancer progression significantly through various dysfunctions both immune cells. Alterations mitochondrial dynamics signaling pathways exert crucial regulatory influence on activation, proliferation, differentiation The microenvironment orchestrates activation functionality tumor-infiltrating by inducing shifts dynamics, thereby facilitating establishment a immunosuppressive microenvironment. Stress-induced leakage DNA contributes multifaceted effects anti-tumor responses activating multiple natural signals, including cGAS-STING, TLR9, NLRP3. Moreover, DNA-mediated immunogenic cell death emerges as promising avenue immunotherapy. Additionally, reactive oxygen species, factor tumorigenesis, drives formation changing composition within This review focuses intrinsic relationship between biology from angles. We explore core role mitochondria dynamic interplay host facilitate development targeted strategies

Language: Английский

Citations

5

Exosome-derived microRNAs: emerging players in vitiligo DOI Creative Commons

Wenquan li,

Yaobin Pang,

Qingying He

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: July 8, 2024

Exosome-derived microRNAs (miRNAs) are biomacromolecules and nanoscale extracellular vesicles originating from intracellular compartments that secreted by most cells into the space. This review examines formation function of exosomal miRNAs in biological information transfer, explores pathogenesis vitiligo, highlights relationship between vitiligo. The aim is to deepen understanding how influence immune imbalance, oxidative stress damage, melanocyte-keratinocyte interactions, melanogenesis disorders development enhanced may contribute potential diagnostic therapeutic options for

Language: Английский

Citations

5

Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances DOI Creative Commons
Endong Zhang,

Philana Phan,

Zongmin Zhao

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2022, Volume and Issue: 13(5), P. 1789 - 1827

Published: Aug. 28, 2022

Cellular nanovesicles which are referred to as cell-derived, nanosized lipid bilayer structures, have emerged a promising platform for regulating immune responses. Owing their outstanding advantages such high biocompatibility, prominent structural stability, and loading capacity, cellular suitable delivering various immunomodulatory molecules, small nucleic acids, peptides, proteins. Immunomodulation induced by has been exploited modulate cell behaviors, is considered novel cell-free immunotherapeutic strategy the prevention treatment of diverse diseases. Here we review emerging concepts new advances in leveraging activate or suppress responses, with aim explicate applications immunomodulation. We overview general considerations principles design engineered tailored activities. also discuss engineering immunotherapies treating major

Language: Английский

Citations

21

Amuc_1434 From Akkermansia muciniphila Enhances CD8+ T Cell‐Mediated Anti‐Tumor Immunity by Suppressing PDL1 in Colorectal Cancer DOI
Jiahao Zhu,

Shaolei Qin,

Ruike Gu

et al.

The FASEB Journal, Journal Year: 2025, Volume and Issue: 39(8)

Published: April 15, 2025

ABSTRACT Colorectal cancer (CRC) shows a limited response to programmed death‐ligand 1 (PD‐L1) immunotherapies. Akkermansia muciniphila (AKK) may enhance tumor immunity. This study examines how its Outer Membrane Vesicles (OMVs) and Amuc_1434 influence PD‐L1 expression CD8+ T cell activity in CRC. OMVs were isolated their characteristics examined through transmission electron microscopy Western blotting. was quantified via blot, while proliferation measured using flow cytometry. Cytokine production (interferon‐gamma (IFN‐γ) interleukin‐2 (IL‐2)) evaluated ELISA. A CRC mouse model employed examine impact on growth immune infiltration. In cells, treatment with AKK‐derived (AKK‐OMVs) significantly downregulated ( p < 0.05) markedly increased the levels of IFN‐γ IL‐2 0.01). identified as key protein mediating these effects. vivo, AKK‐OMVs substantially reduced volume 0.01) enhanced infiltration into microenvironment Additionally, AKK‐OMVs‐treated mice showed activation markers within tissue, further indicating antitumor reveals that AKK‐OMVs, particularly those containing Amuc_1434, can modulate potentiate cell‐mediated immunity These findings suggest novel approach overcoming resistance checkpoint inhibitors

Language: Английский

Citations

0

PIWI-RNAs Small Noncoding RNAs with Smart Functions: Potential Theranostic Applications in Cancer DOI Open Access
Simona Taverna,

Anna Masucci,

Giuseppe Cammarata

et al.

Cancers, Journal Year: 2023, Volume and Issue: 15(15), P. 3912 - 3912

Published: Aug. 1, 2023

P-element-induced wimpy testis (PIWI)-interacting RNAs (piRNAs) are a new class of small noncoding (ncRNAs) that bind components the PIWI protein family. piRNAs specifically expressed in different human tissues and regulate important signaling pathways. Aberrant expressions proteins have been associated with tumorigenesis cancer progression. Recent studies reported contained extracellular vesicles (EVs), nanosized lipid particles, key roles cell–cell communication. EVs contain several bioactive molecules, such as proteins, lipids, nucleic acids, including emerging ncRNAs. one liquid biopsy (LB) non-invasive method for detecting specific molecular biomarkers samples. LB could become crucial tool diagnosis precision oncology approach. This review summarizes current findings on types, focusing potential theranostic applications (EV-piRNAs). Their diagnostic prognostic therapeutic options also discussed.

Language: Английский

Citations

10

PKCα regulates the secretion of PDL1-carrying small extracellular vesicles in a p53-dependent manner DOI Creative Commons
Ren Zhang, Weilin Liao, Xi Chen

et al.

Cell Death and Disease, Journal Year: 2025, Volume and Issue: 16(1)

Published: Jan. 14, 2025

Small extracellular vesicles (sEVs), carrying PD-L1, have been implicated in immune evasion and tumor progression. However, understanding how PD-L1 sEVs are secreted still needs to be improved. We found that the secretion dynamics of is similar other sEVs. Intracellular calcium associated downstream PKC signaling plays pivotal roles releasing non-small cell lung cancer cells (NSCLC). Particularly, we observed knocking down PKCα has profound impacts on secretion, especially resting state activated state, when induced by an intracellular rise. Furthermore, our study revealed regulates expression influencing STAT1 phosphorylation nuclear translocation a p53-dependent manner. Notably, p53 can regulate localization, but it does not affect expression. This suggests significant role regulating Our findings suggest targeting modulate NSCLC may promising therapeutic strategy enhance efficacy immunotherapeutic interventions.

Language: Английский

Citations

0

Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors DOI Creative Commons
Xingyi Wang, Hanyi Fang,

Wenzhu Hu

et al.

Journal of Nanobiotechnology, Journal Year: 2025, Volume and Issue: 23(1)

Published: March 7, 2025

Limited treatment response and inadequate monitoring methods stand firmly before successful immunotherapy. Recruiting activating immune cells in the hypoxic tumor microenvironment is key to reversing suppression improving immunotherapy efficacy. In this study, biomimetic oxygen-delivering nanoparticles (CmPF) are engineered for homologous targeting hypoxia alleviation within environment. CmPF targets delivers oxygen reduce hypoxia, thereby promoting cell activity at site. addition, granzyme B-targeted positron emission tomography (PET) imaging employed monitor changes efficacy vivo. The combination of with carboplatin PD-1 inhibitors significantly suppresses growth by 2.4-fold, exhibiting potential enhance Immunohistochemistry further confirms increased expression markers, highlighting reprogramming microenvironment. This study demonstrates that enhances introduces a non-invasive PET method dynamic, real-time assessment therapeutic response.

Language: Английский

Citations

0

Challenges and the Evolving Landscape of Assessing Blood-Based PD-L1 Expression as a Biomarker for Anti-PD-(L)1 Immunotherapy DOI Creative Commons
Tao Wang,

Desirée Denman,

Silvia M. Bacot

et al.

Biomedicines, Journal Year: 2022, Volume and Issue: 10(5), P. 1181 - 1181

Published: May 20, 2022

While promising, PD-L1 expression on tumor tissues as assessed by immunohistochemistry has been shown to be an imperfect biomarker that only applies a limited number of cancers, whereas many patients with PD-L1-negative tumors still respond anti-PD-(L)1 immunotherapy. Recent studies using patient blood samples assess immunotherapeutic responsiveness suggests promising approach the identification novel and/or improved biomarkers for In this review, we discuss advances in our evolving understanding regulation and function expression, which is foundation developing blood-based We further current knowledge clinical study results immune cells, exosomes, soluble forms peripheral blood. Finally, key challenges successful development potential use

Language: Английский

Citations

16

PD-L1, STAT3, IL6, and EGFR Immunoexpressions in High-Grade Osteosarcoma DOI Creative Commons
Nayla Rahmadiani, Eviana Norahmawati, Agustina Tri Endharti

et al.

Advances in Orthopedics, Journal Year: 2024, Volume and Issue: 2024, P. 1 - 7

Published: Feb. 23, 2024

Introduction. Immunotherapy has been widely used in the treatment of various malignancies with satisfactory results. One agents for immunotherapy is an inhibitor programmed cell death-1 and its ligands (PD-1 PD-L1). However, attempts at utilizing PD-1/PD-L1 osteosarcoma have not yielded favorable This may be due to differences PD-L1 regulation immune landscape osteosarcoma, as mechanism still poorly understood. Therefore, elucidating paramount order improve results using immunotherapy. Methods. a cross-sectional study conducted Department Anatomical Pathology Saiful Anwar Hospital 33 paraffin blocks confirmed cases osteosarcoma. Immunohistochemical staining PD-L1, STAT3, IL6, EGFR was performed. Statistical analyses were subsequently performed on immunoexpression data these antibodies. Results. expressions found 6 (18.2%), 28 (84.8%), 30 (90.9%) cases, respectively. There significant correlations between STAT3 (r = 0.620, p=<0.001 ), 0.449, p=0.009 well 0.351, p=0.045 ). Conclusion. The existence correlation indicates potential role which become basis targeted therapy.

Language: Английский

Citations

3